Old Web
English
Sign In
Acemap
>
authorDetail
>
Alison Wolfreys
Alison Wolfreys
UCB
Myocardial infarction
Stroke
Medicine
Romosozumab
Internal medicine
3
Papers
20
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Sclerostin Downregulation Globally by Naturally Occurring Genetic Variants, or Locally in Atherosclerotic Plaques, Does Not Associate With Cardiovascular Events in Humans.
2021
Journal of Bone and Mineral Research
Gill Holdsworth
James R Staley
Peter Hall
Ian D. van Koeverden
Ciara Vangjeli
Remi Okoye
Rogely W. Boyce
James R. Turk
Martin Armstrong
Alison Wolfreys
Gerard Pasterkamp
Show All
Source
Cite
Save
Citations (4)
Genetic and atherosclerotic plaque immunohistochemical analyses do not associate reduced sclerostin expression with cardiovascular events
2020
medRxiv
Gill Holdsworth
James R Staley
Peter Hall
Ian D. van Koeverden
Ciara Vangjeli
Remi Okoye
Rogely W. Boyce
James R. Turk
Martin Armstrong
Alison Wolfreys
Gerard Pasterkamp
Show All
Source
Cite
Save
Citations (0)
Nonclinical cardiovascular safety evaluation of romosozumab, an inhibitor of sclerostin for the treatment of osteoporosis in postmenopausal women at high risk of fracture.
2020
Regulatory Toxicology and Pharmacology
James R. Turk
Aimée M. Deaton
Jun Yin
Marina Stolina
Melanie Felx
Gabrielle Boyd
Jean-Guy Bienvenu
Aurore Varela
Martin Guillot
Gill Holdsworth
Alison Wolfreys
Denise Dwyer
Sheetal V. Kumar
Emily M. de Koning
Yusheng Qu
Michael Engwall
Kathrin Locher
Lucas D. Ward
Charles Glaus
Yudong D. He
Rogely W. Boyce
Show All
Source
Cite
Save
Citations (16)
1